Skip to main content

Research Repository

Advanced Search

Endocannabinoids in aqueous humour of patients with or without diabetes

Richardson, Patrick S.; Ortori, Catherine; Barrett, David A.; O'Sullivan, Saoirse E.; Idris, Iskandar

Endocannabinoids in aqueous humour of patients with or without diabetes Thumbnail


Authors

Patrick S. Richardson

Catherine Ortori

David A. Barrett

Saoirse E. O'Sullivan

ISKANDAR IDRIS Iskandar.Idris@nottingham.ac.uk
Professor of Diabetes and Metabolic Medicine



Abstract

Objective The primary aim was to determine endocannabinoid (EC) concentrations of 2-arachidonoylglycerol (2-AG), oleoylethanolamine (OEA), palmitoylethanolamine (PEA) and anandamide (AEA) in the aqueous humour of patients, and to investigate any differences in gender and diabetic or ocular disease status.

Methods and Analysis Adult participants (age >18 years) listed for a routine cataract surgery were recruited. For patients with diabetes, results from their most recent retinopathy grading were recorded. A sample of aqueous humour was removed from the anterior chamber of the patients and snap-frozen in liquid nitrogen. Levels of 2-AG, PEA, OEA and AEA were measured by liquid chromatography-tandem mass spectrometry.

Results Aqueous humour samples were taken from 93 patients (female:male=58:35), with a mean age±SD of 72.7±9.5 years. Following gender-specific analysis, the mean aqueous concentration of AEA in female patients without diabetes was significantly higher than in female patients with diabetes (0.20±0.03 nM vs 0.07±0.02 nM, p=0.001). Among female patients with diabetes, the aqueous concentration of 2-AG was higher in those with diabetic retinopathy compared with those with no retinopathy (0.30+0.16 nM vs 0.04±0.01 nM, p=0.0025). The aqueous level of the sum of EC was higher in those with ocular comorbidity (2.49±0.73 vs 1.44±0.17, p=0.0002).

Conclusion There were gender, diabetes status and comorbidity differences in aqueous humour EC levels. Since EC receptors are present in ocular tissues, including the retina (neurons, glia and endothelial cells), differential levels of ECs in the aqueous humour of patients with and without diabetes may provide a novel therapeutic target for diabetic retinopathy.

Citation

Richardson, P. S., Ortori, C., Barrett, D. A., O'Sullivan, S. E., & Idris, I. (2020). Endocannabinoids in aqueous humour of patients with or without diabetes. BMJ Open Ophthalmology, 5(1), Article e000425. https://doi.org/10.1136/bmjophth-2019-000425

Journal Article Type Article
Acceptance Date Jan 21, 2020
Online Publication Date Feb 17, 2020
Publication Date Feb 17, 2020
Deposit Date Feb 4, 2020
Publicly Available Date Feb 17, 2020
Journal BMJ Open Opthalmology
Print ISSN 2397-3269
Electronic ISSN 2397-3269
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 5
Issue 1
Article Number e000425
DOI https://doi.org/10.1136/bmjophth-2019-000425
Keywords diabetes; retinopathy; maculopathy; endocannabinoid; ocular fluid
Public URL https://nottingham-repository.worktribe.com/output/3888643
Publisher URL https://bmjophth.bmj.com/content/5/1/e000425

Files





Downloadable Citations